Status:
COMPLETED
Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Smoking Behaviors
Eligibility:
All Genders
18+ years
Brief Summary
Several studies have shown that smokers have a higher risk of developing a severe form of COVID-19 once a person has been infected. This is explained by the damage caused by smoking at the bronchopulm...
Eligibility Criteria
Inclusion
- Age \> 18 years old
- Subject who will require a serological test for COVID-19 virus as part of standard of care.
- Group 1: Active smoker since October 2019
- Group 2: Smoker undergoing smoking cessation and taking nicotine substitutes on a regular basis since October 2019
- Group 3: Non-smoker
Exclusion
- Inpatient subject
- Subjects with a chronic serious pathology modifying the risk of exposure to COVID-19
Key Trial Info
Start Date :
August 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 26 2021
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT04429815
Start Date
August 25 2020
End Date
May 26 2021
Last Update
August 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy
Vandœuvre-lès-Nancy, France